Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary

Masakuni Noguchi1

  • 1Surgical Center, Kanazawa University Hospital, Takara-machi, 13-1, Kanazawa 920-8640, Japan.

Breast Cancer (Tokyo, Japan)
|September 5, 2003
PubMed
Summary

Sentinel lymph node (SLN) biopsy is a valuable tool for breast cancer staging. However, long-term data is lacking on whether SLN biopsy alone is sufficient, necessitating further research before abandoning axillary dissection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omission of axillary dissection in patients with microscopic residual nodal disease after neoadjuvant chemotherapy.

Gland surgery·2026
Same author

Oncological Feasibility of Conservative Axillary Surgery (Opinion Article): Tailored Axillary Surgery vs. Axillary Reverse Mapping-Guided Axillary Lymph Node Dissection.

Cancers·2026
Same author

Periarterial or perivenous invasion is an independent indicator of lymph node metastasis in invasive breast carcinoma of no special type.

Pathology, research and practice·2024
Same author

Conservative Axillary Surgery May Prevent Arm Lymphedema without Increasing Axillary Recurrence in the Surgical Management of Breast Cancer.

Cancers·2023
Same author

Axillary Reverse Mapping in Clinically Node-Positive Breast Cancer Patients.

Cancers·2023
Same author

The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2023

Area of Science:

  • Oncology
  • Surgical Oncology
  • Breast Cancer Research

Background:

  • Sentinel lymph node (SLN) biopsy is established for axillary staging in breast cancer.
  • Surgeons are increasingly omitting axillary dissection based on negative SLN biopsy results.
  • Limited long-term outcome data exists comparing SLN biopsy alone versus axillary dissection.

Purpose of the Study:

  • To review and discuss the significance of ongoing prospective randomized trials.
  • To evaluate the potential elimination of axillary dissection in breast cancer management.
  • To assess the risks and benefits of SLN biopsy alone versus axillary dissection.

Main Methods:

  • Review of current literature and ongoing prospective randomized clinical trials.
  • Discussion of the implications of SLN biopsy in breast cancer staging.

Related Experiment Videos

  • Analysis of the false-negative rates and their impact on axillary recurrence.

    • Main Results:

    • SLN biopsy has a known false-negative rate, potentially leaving residual disease.
    • The impact of SLN biopsy alone on axillary recurrence rates, especially in high-risk patients, remains uncertain.
    • The overall benefit-risk profile of SLN biopsy alone compared to axillary dissection is not fully established.

    Conclusions:

    • Prospective randomized trials with long-term regional control and survival data are essential.
    • Routine axillary dissection should not be abandoned without extensive experience and a documented low false-negative rate.
    • Patients undergoing SLN biopsy without axillary dissection must be informed of the false-negative risk.